EMERGENCY MEDICATION WHEN YOU NEED IT
Mobile Phone Autoinjector
Archimedic collaborated with Thomas Jefferson University (TJU) in the development of a compact autoinjector integrated into a cellphone case. This drug delivery platform is intended for medical emergencies, such as allergic reactions and overdoses.
CONFIGURATION DEVELOPMENT
Safety Focused Use Cases
The project started by exploring various use cases to activate the autoinjector while mitigating any usability risks. Several concepts were explored at a sketch-level before landing on the primary direction.
SEQUENCING DEVICE ACTUATIONS
Mechanism Development
Next, a mechanical layout was constructed to define the required actuations from injection through medication dispensing, and needle retraction. These mechanisms were constructed through dynamic computer-aided design (CAD) models and analyzed through simulated motion studies.
ISOLATING FEATURES AND SUBSYSTEMS
Subsystem Prototyping
To evaluate key features and functionalities, we isolated critical subsystems (such as latching details) and built iterative rapid prototypes until the functionality was reliably achieved.
FUNCTIONAL TESTING
Prototyping & Testing
Various prototypes were developed to achieve the desired performance. Iterations focused on miniaturization of the mechanisms and achieving critical injection force and speed design inputs. High speed cameras, thermal monitoring, and ballistic gels were used in the testing process.
INSPIRED BY PERSONAL EXPERIENCE
Empowering a Clinical Visionary
This brief video shares Dr. Edmund Pribitkin's vision for the Epicase and how we worked together in making it a reality. Note, this video illustrates an early prototype of the Epicase device, developed by Smithwise, which later became Archimedic through a merger.
Learn how we develop new drug delivery devices.
Watch our video series for a step-by-step overview of our ISO 13485 certified medical device development process.
WATCH VIDEO SERIESReady to discuss your project?
Click the link below to see how we start the conversation and explore collaborations.
GET STARTED